25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Axim Biotechnologies Inc
Buy, Hold or Sell?

Let's analyze Axim Biotechnologies Inc together

I guess you are interested in Axim Biotechnologies Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Axim Biotechnologies Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Axim Biotechnologies Inc

I send you an email if I find something interesting about Axim Biotechnologies Inc.

1. Quick Overview

1.1. Quick analysis of Axim Biotechnologies Inc (30 sec.)










1.2. What can you expect buying and holding a share of Axim Biotechnologies Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.03
Expected worth in 1 year
$-0.03
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
23.9%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.002 - $0.005
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Axim Biotechnologies Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-0.08 - $0.01
Total Value Per Share
$-0.11 - $-0.02

2.2. Growth of Axim Biotechnologies Inc (5 min.)




Is Axim Biotechnologies Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$9.5m-$6.2m-$1.3m-17.8%

How much money is Axim Biotechnologies Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1m-$2.3m$1.3m127.8%
Net Profit Margin-6,225.6%-60,393.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Axim Biotechnologies Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#886 / 950

Most Revenue
#728 / 950

Most Profit
#246 / 950

Most Efficient
#847 / 950
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Axim Biotechnologies Inc?

Welcome investor! Axim Biotechnologies Inc's management wants to use your money to grow the business. In return you get a share of Axim Biotechnologies Inc.

First you should know what it really means to hold a share of Axim Biotechnologies Inc. And how you can make/lose money.

Speculation

The Price per Share of Axim Biotechnologies Inc is $0.003. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Axim Biotechnologies Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Axim Biotechnologies Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.03. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Axim Biotechnologies Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-250.6%0.00-117.5%-0.01-260.0%-0.01-230.3%-0.01-184.1%
Usd Book Value Change Per Share-0.01-232.4%0.006.0%0.00-166.1%0.00-18.6%0.00-26.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-232.4%0.006.0%0.00-166.1%0.00-18.6%0.00-26.2%
Usd Price Per Share0.01-0.02-0.05-0.27-1.73-
Price to Earnings Ratio-0.33-0.87--1.83--24.02--137.88-
Price-to-Total Gains Ratio-1.43-3.51--18.38--460.80--564.44-
Price to Book Ratio-0.32--0.81--2.69-21.62--120.05-
Price-to-Total Gains Ratio-1.43-3.51--18.38--460.80--564.44-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.003
Number of shares333333
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (333333 shares)59.84-186.17
Gains per Year (333333 shares)239.34-744.68
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102392290-745-755
204794680-1489-1500
307187070-2234-2245
409579460-2979-2990
50119711850-3723-3735
60143614240-4468-4480
70167516630-5213-5225
80191519020-5957-5970
90215421410-6702-6715
100239323800-7447-7460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.019.00.05.0%3.035.02.07.5%3.037.010.06.0%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%7.013.00.035.0%13.027.00.032.5%16.034.00.032.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.050.00.0%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%7.013.00.035.0%13.027.00.032.5%16.034.00.032.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Axim Biotechnologies Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0070.000-3983%-0.005-29%-0.001-92%-0.001-89%
Book Value Per Share---0.032-0.023-26%-0.021-34%-0.011-66%-0.011-65%
Current Ratio--0.0030.014-78%0.033-91%0.252-99%0.361-99%
Debt To Asset Ratio--3.5572.941+21%2.486+43%2.065+72%3.126+14%
Debt To Equity Ratio----0%-0%2.216-100%1.175-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.008-0.004-53%-0.008+4%-0.007-8%-0.006-27%
Free Cash Flow Per Share---0.001-0.001+41%-0.001+36%-0.002+155%-0.002+153%
Free Cash Flow To Equity Per Share--0.0000.000-82%0.000-1222%0.000+46%0.000-160%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.950+5%
Intrinsic Value_10Y_max--0.008--------
Intrinsic Value_10Y_min---0.080--------
Intrinsic Value_1Y_max---0.005--------
Intrinsic Value_1Y_min---0.009--------
Intrinsic Value_3Y_max---0.011--------
Intrinsic Value_3Y_min---0.026--------
Intrinsic Value_5Y_max---0.011--------
Intrinsic Value_5Y_min---0.042--------
Market Cap905877.024-233%3019590.0805607241.866-46%13814624.616-78%83070103.554-96%521182592.932-99%
Net Profit Margin---129.860-62.256-52%-603.935+365%-631.354+386%-364.220+180%
Operating Margin---32.578-25.410-22%-288.517+786%-555.762+1606%-314.832+866%
Operating Ratio--33.57943.853-23%331.103-90%-129.977+487%-32.487+197%
Pb Ratio-0.095+70%-0.317-0.810+156%-2.691+750%21.624-101%-120.051+37804%
Pe Ratio-0.100+70%-0.3330.866-138%-1.835+452%-24.020+7122%-137.884+41359%
Price Per Share0.003-233%0.0100.016-35%0.046-78%0.274-96%1.726-99%
Price To Free Cash Flow Ratio-0.866+70%-2.88615.028-119%-11.497+298%-25.998+801%-360.055+12374%
Price To Total Gains Ratio-0.430+70%-1.4343.514-141%-18.384+1182%-460.798+32023%-564.444+39248%
Quick Ratio---0.0010.006-120%--100%0.156-101%0.237-101%
Return On Assets---0.609-0.266-56%-0.557-9%-0.397-35%-0.648+6%
Return On Equity----0%-0%-0.4560%-0.2740%
Total Gains Per Share---0.0070.000-3983%-0.005-29%-0.001-92%-0.001-89%
Usd Book Value---9533790.000-7643573.500-20%-6279416.750-34%-3316021.550-65%-3418462.925-64%
Usd Book Value Change Per Share---0.0070.000-3983%-0.005-29%-0.001-92%-0.001-89%
Usd Book Value Per Share---0.032-0.023-26%-0.021-34%-0.011-66%-0.011-65%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.008-0.004-53%-0.008+4%-0.007-8%-0.006-27%
Usd Free Cash Flow---261540.000-394096.750+51%-356248.250+36%-671070.800+157%-629935.475+141%
Usd Free Cash Flow Per Share---0.001-0.001+41%-0.001+36%-0.002+155%-0.002+153%
Usd Free Cash Flow To Equity Per Share--0.0000.000-82%0.000-1222%0.000+46%0.000-160%
Usd Market Cap905877.024-233%3019590.0805607241.866-46%13814624.616-78%83070103.554-96%521182592.932-99%
Usd Price Per Share0.003-233%0.0100.016-35%0.046-78%0.274-96%1.726-99%
Usd Profit---2269815.000-1033968.250-54%-2354880.000+4%-2080332.950-8%-1627735.100-28%
Usd Revenue--17479.00023224.500-25%6550.250+167%37992.650-54%30232.500-42%
Usd Total Gains Per Share---0.0070.000-3983%-0.005-29%-0.001-92%-0.001-89%
 EOD+2 -6MRQTTM+7 -24YOY+12 -195Y+11 -2110Y+10 -23

3.3 Fundamental Score

Let's check the fundamental score of Axim Biotechnologies Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.100
Price to Book Ratio (EOD)Between0-1-0.095
Net Profit Margin (MRQ)Greater than0-129.860
Operating Margin (MRQ)Greater than0-32.578
Quick Ratio (MRQ)Greater than1-0.001
Current Ratio (MRQ)Greater than10.003
Debt to Asset Ratio (MRQ)Less than13.557
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.609
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Axim Biotechnologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.030
Ma 20Greater thanMa 500.004
Ma 50Greater thanMa 1000.004
Ma 100Greater thanMa 2000.007
OpenGreater thanClose0.002
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Axim Biotechnologies Inc

AXIM Biotechnologies, Inc. engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.

Fundamental data was last updated by Penke on 2024-11-10 00:08:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Axim Biotechnologies Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Axim Biotechnologies Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -12,986.0% means that $-129.86 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Axim Biotechnologies Inc:

  • The MRQ is -12,986.0%. The company is making a huge loss. -2
  • The TTM is -6,225.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-12,986.0%TTM-6,225.6%-6,760.4%
TTM-6,225.6%YOY-60,393.5%+54,167.9%
TTM-6,225.6%5Y-63,135.4%+56,909.8%
5Y-63,135.4%10Y-36,422.0%-26,713.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12,986.0%-110.9%-12,875.1%
TTM-6,225.6%-214.4%-6,011.2%
YOY-60,393.5%-210.0%-60,183.5%
5Y-63,135.4%-339.1%-62,796.3%
10Y-36,422.0%-464.5%-35,957.5%
4.3.1.2. Return on Assets

Shows how efficient Axim Biotechnologies Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Axim Biotechnologies Inc to the Biotechnology industry mean.
  • -60.9% Return on Assets means that Axim Biotechnologies Inc generated $-0.61 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Axim Biotechnologies Inc:

  • The MRQ is -60.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -26.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-60.9%TTM-26.6%-34.3%
TTM-26.6%YOY-55.7%+29.1%
TTM-26.6%5Y-39.7%+13.1%
5Y-39.7%10Y-64.8%+25.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-60.9%-11.2%-49.7%
TTM-26.6%-11.7%-14.9%
YOY-55.7%-11.3%-44.4%
5Y-39.7%-12.7%-27.0%
10Y-64.8%-14.2%-50.6%
4.3.1.3. Return on Equity

Shows how efficient Axim Biotechnologies Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Axim Biotechnologies Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Axim Biotechnologies Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Axim Biotechnologies Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-45.6%+45.6%
5Y-45.6%10Y-27.4%-18.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.2%+14.2%
TTM--15.8%+15.8%
YOY--14.2%+14.2%
5Y-45.6%-18.5%-27.1%
10Y-27.4%-19.5%-7.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Axim Biotechnologies Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Axim Biotechnologies Inc is operating .

  • Measures how much profit Axim Biotechnologies Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Axim Biotechnologies Inc to the Biotechnology industry mean.
  • An Operating Margin of -3,257.8% means the company generated $-32.58  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Axim Biotechnologies Inc:

  • The MRQ is -3,257.8%. The company is operating very inefficient. -2
  • The TTM is -2,541.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-3,257.8%TTM-2,541.0%-716.9%
TTM-2,541.0%YOY-28,851.7%+26,310.8%
TTM-2,541.0%5Y-55,576.2%+53,035.3%
5Y-55,576.2%10Y-31,483.2%-24,093.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,257.8%-222.9%-3,034.9%
TTM-2,541.0%-306.4%-2,234.6%
YOY-28,851.7%-221.9%-28,629.8%
5Y-55,576.2%-387.1%-55,189.1%
10Y-31,483.2%-498.7%-30,984.5%
4.3.2.2. Operating Ratio

Measures how efficient Axim Biotechnologies Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 33.58 means that the operating costs are $33.58 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Axim Biotechnologies Inc:

  • The MRQ is 33.579. The company is inefficient in keeping operating costs low. -1
  • The TTM is 43.853. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ33.579TTM43.853-10.274
TTM43.853YOY331.103-287.250
TTM43.8535Y-129.977+173.830
5Y-129.97710Y-32.487-97.490
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ33.5792.465+31.114
TTM43.8533.244+40.609
YOY331.1033.298+327.805
5Y-129.9774.788-134.765
10Y-32.4876.517-39.004
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Axim Biotechnologies Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Axim Biotechnologies Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.00 means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Axim Biotechnologies Inc:

  • The MRQ is 0.003. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.014. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.003TTM0.014-0.011
TTM0.014YOY0.033-0.019
TTM0.0145Y0.252-0.238
5Y0.25210Y0.361-0.110
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0033.610-3.607
TTM0.0143.877-3.863
YOY0.0334.633-4.600
5Y0.2525.938-5.686
10Y0.3616.265-5.904
4.4.3.2. Quick Ratio

Measures if Axim Biotechnologies Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Axim Biotechnologies Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Axim Biotechnologies Inc:

  • The MRQ is -0.001. The company is unable to pay all its short-term debts with the most liquid assets. -2
  • The TTM is 0.006. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ-0.001TTM0.006-0.007
TTM0.006YOY-+0.006
TTM0.0065Y0.156-0.150
5Y0.15610Y0.237-0.081
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0013.048-3.049
TTM0.0063.426-3.420
YOY-4.449-4.449
5Y0.1565.927-5.771
10Y0.2376.424-6.187
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Axim Biotechnologies Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Axim Biotechnologies Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Axim Biotechnologies Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 3.56 means that Axim Biotechnologies Inc assets are financed with 355.7% credit (debt) and the remaining percentage (100% - 355.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Axim Biotechnologies Inc:

  • The MRQ is 3.557. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.941. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ3.557TTM2.941+0.615
TTM2.941YOY2.486+0.456
TTM2.9415Y2.065+0.877
5Y2.06510Y3.126-1.061
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5570.353+3.204
TTM2.9410.346+2.595
YOY2.4860.311+2.175
5Y2.0650.366+1.699
10Y3.1260.383+2.743
4.5.4.2. Debt to Equity Ratio

Measures if Axim Biotechnologies Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Axim Biotechnologies Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Axim Biotechnologies Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y2.216-2.216
5Y2.21610Y1.175+1.041
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.395-0.395
TTM-0.435-0.435
YOY-0.380-0.380
5Y2.2160.451+1.765
10Y1.1750.493+0.682
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Axim Biotechnologies Inc generates.

  • Above 15 is considered overpriced but always compare Axim Biotechnologies Inc to the Biotechnology industry mean.
  • A PE ratio of -0.33 means the investor is paying $-0.33 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Axim Biotechnologies Inc:

  • The EOD is -0.100. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.333. Based on the earnings, the company is expensive. -2
  • The TTM is 0.866. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-0.100MRQ-0.333+0.233
MRQ-0.333TTM0.866-1.198
TTM0.866YOY-1.835+2.700
TTM0.8665Y-24.020+24.885
5Y-24.02010Y-137.884+113.864
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.100-2.251+2.151
MRQ-0.333-2.398+2.065
TTM0.866-3.147+4.013
YOY-1.835-3.237+1.402
5Y-24.020-6.021-17.999
10Y-137.884-6.731-131.153
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Axim Biotechnologies Inc:

  • The EOD is -0.866. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.886. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 15.028. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-0.866MRQ-2.886+2.020
MRQ-2.886TTM15.028-17.915
TTM15.028YOY-11.497+26.525
TTM15.0285Y-25.998+41.026
5Y-25.99810Y-360.055+334.057
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.866-2.954+2.088
MRQ-2.886-3.234+0.348
TTM15.028-3.730+18.758
YOY-11.497-4.523-6.974
5Y-25.998-8.196-17.802
10Y-360.055-9.244-350.811
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Axim Biotechnologies Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.32 means the investor is paying $-0.32 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Axim Biotechnologies Inc:

  • The EOD is -0.095. Based on the equity, the company is expensive. -2
  • The MRQ is -0.317. Based on the equity, the company is expensive. -2
  • The TTM is -0.810. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.095MRQ-0.317+0.222
MRQ-0.317TTM-0.810+0.494
TTM-0.810YOY-2.691+1.881
TTM-0.8105Y21.624-22.434
5Y21.62410Y-120.051+141.675
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0951.931-2.026
MRQ-0.3172.039-2.356
TTM-0.8102.343-3.153
YOY-2.6912.431-5.122
5Y21.6243.698+17.926
10Y-120.0514.362-124.413
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets3,729
Total Liabilities13,262
Total Stockholder Equity-9,534
 As reported
Total Liabilities 13,262
Total Stockholder Equity+ -9,534
Total Assets = 3,729

Assets

Total Assets3,729
Total Current Assets20
Long-term Assets3,708
Total Current Assets
Cash And Cash Equivalents 6
Net Receivables -14
Inventory 14
Other Current Assets 14
Total Current Assets  (as reported)20
Total Current Assets  (calculated)20
+/-0
Long-term Assets
Property Plant Equipment 301
Intangible Assets 3,398
Long-term Assets Other 9
Long-term Assets  (as reported)3,708
Long-term Assets  (calculated)3,707
+/- 1

Liabilities & Shareholders' Equity

Total Current Liabilities6,572
Long-term Liabilities6,690
Total Stockholder Equity-9,534
Total Current Liabilities
Short-term Debt 93
Accounts payable 1,674
Other Current Liabilities 4,573
Total Current Liabilities  (as reported)6,572
Total Current Liabilities  (calculated)6,340
+/- 233
Long-term Liabilities
Long term Debt 6,596
Capital Lease Obligations Min Short Term Debt94
Long-term Liabilities  (as reported)6,690
Long-term Liabilities  (calculated)6,690
+/- 0
Total Stockholder Equity
Common Stock29
Retained Earnings -74,747
Other Stockholders Equity 65,184
Total Stockholder Equity (as reported)-9,534
Total Stockholder Equity (calculated)-9,534
+/-0
Other
Capital Stock29
Cash and Short Term Investments 6
Common Stock Shares Outstanding 288,913
Current Deferred Revenue233
Liabilities and Stockholders Equity 3,729
Net Debt 6,402
Net Invested Capital -2,939
Net Working Capital -6,552
Property Plant and Equipment Gross 442
Short Long Term Debt Total 6,408



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-30
> Total Assets 
13
87
58
68
133
126
96
91
57
52
5
1,062
738
236
3,105
1,825
1,262
655
481
1,230
1,449
825
4,414
3,322
2,192
834
686
792
2,089
3,018
2,882
2,377
1,692
10,915
11,072
12,129
11,314
11,268
10,353
14,248
5,323
5,064
4,521
4,479
4,212
4,043
4,246
4,044
4,122
3,954
3,729
3,7293,9544,1224,0444,2464,0434,2124,4794,5215,0645,32314,24810,35311,26811,31412,12911,07210,9151,6922,3772,8823,0182,0897926868342,1923,3224,4148251,4491,2304816551,2621,8253,1052367381,06255257919612613368588713
   > Total Current Assets 
13
0
0
0
0
0
0
0
3
0
5
1,062
738
236
2,122
1,746
1,183
577
404
1,154
1,374
743
4,332
3,242
2,113
765
618
724
2,023
2,960
2,826
2,322
1,639
1,138
1,126
1,616
713
667
412
500
637
498
173
249
104
57
97
23
156
97
20
20971562397571042491734986375004126677131,6161,1261,1381,6392,3222,8262,9602,0237246187652,1133,2424,3327431,3741,1544045771,1831,7462,1222367381,062503000000013
       Cash And Cash Equivalents 
13
39
2
8
19
14
0
1
0
0
5
950
661
195
32
43
134
171
19
871
713
632
4,104
3,082
2,058
726
515
632
1,806
2,662
2,208
1,167
512
443
891
1,157
457
449
202
338
453
408
65
164
47
54
97
23
156
97
6
69715623975447164654084533382024494571,1578914435121,1672,2082,6621,8066325157262,0583,0824,104632713871191711344332195661950500101419823913
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
150
175
316
432
241
137
27
27
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000027271372414323161751500000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
3
0
0
0
5
5
5
5
5
5
5
5
505
5
5
5
5
5
5
5
5
18
5
39
321
5
103
103
0
33
12
0
0
0
0
0
0
0
0
0
0
0
-14
-1400000000000123301031035321395185555555550555555555000300000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
112
72
35
2,024
1,397
778
223
149
63
41
20
84
62
41
27
92
0
52
26
239
152
105
71
132
355
256
165
177
0
20
0
0
0
14
3
0
0
0
0
14
140000314000200177165256355132711051522392652092274162842041631492237781,3972,024357211200000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
54
52
0
0
0
0
1,967
142
142
78
77
76
139
145
71
71
71
61
61
0
61
53
56
54
53
9,776
9,946
10,415
10,497
10,484
9,941
13,748
4,687
4,567
4,348
4,229
4,108
3,986
4,149
4,021
3,965
3,857
3,708
3,7083,8573,9654,0214,1493,9864,1084,2294,3484,5674,68713,7489,94110,48410,49710,4159,9469,7765354565361061617171711451397677781421421,9670000525400000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16
16
15
14
13
12
11
11
10
9
8
7
6
6
5
4
3
2
25
245
7,898
104
117
111
195
194
172
156
136
114
91
348
318
361
333
301
301333361318348911141361561721941951111171047,89824525234566789101111121314151616000000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,541
3,541
2,458
2,458
2,458
2,458
2,458
0
0
0
0
0
0
0
0
0
0
0
000000000002,4582,4582,4582,4582,4583,5413,541000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
103
103
103
0
0
0
0
0
0
0
0
0
0
0
0
000000000000103103103000000000000000000000000000000000000
       Intangible Assets 
0
48
46
45
94
92
88
86
54
52
0
0
0
0
983
63
63
63
63
63
63
63
63
63
63
54
54
54
54
51
51
51
51
6,197
6,146
7,800
7,800
7,800
7,159
10,986
4,384
4,285
4,187
4,088
3,989
3,891
3,792
3,694
3,595
3,496
3,398
3,3983,4963,5953,6943,7923,8913,9894,0884,1874,2854,38410,9867,1597,8007,8007,8006,1466,19751515151545454546363636363636363636398300005254868892944546480
       Other Assets 
0
48
46
45
94
92
88
86
54
52
0
0
0
0
983
63
63
63
63
63
63
70
71
70
70
7
2
7
7
2
2
1
0
5,913
5,913
7,813
7,908
7,908
7,268
6,613
109
110
5
5
5
0
0
0
0
0
0
0000005551101096,6137,2687,9087,9087,8135,9135,913012277277070717063636363636398300005254868892944546480
> Total Liabilities 
13
77
49
56
138
137
136
142
151
65
55
1,251
1,319
1,287
2,261
2,588
2,957
3,234
3,298
4,468
3,821
3,721
7,842
8,174
8,477
8,652
7,654
6,994
8,171
8,305
9,043
8,554
8,452
11,277
10,072
9,841
9,749
9,640
9,315
9,600
7,662
8,488
8,254
8,859
9,037
10,204
13,997
9,999
11,778
11,383
13,262
13,26211,38311,7789,99913,99710,2049,0378,8598,2548,4887,6629,6009,3159,6409,7499,84110,07211,2778,4528,5549,0438,3058,1716,9947,6548,6528,4778,1747,8423,7213,8214,4683,2983,2342,9572,5882,2611,2871,3191,251556515114213613713856497713
   > Total Current Liabilities 
4
62
18
56
138
137
136
142
151
58
55
1,251
1,319
1,287
1,861
2,188
2,557
2,834
2,988
4,151
3,017
2,873
4,934
6,726
7,705
7,919
6,890
6,193
3,324
3,390
4,121
3,565
3,395
4,381
2,948
1,600
1,496
1,314
1,364
1,595
2,581
3,361
2,712
3,163
3,392
4,863
8,365
4,278
5,978
4,803
6,572
6,5724,8035,9784,2788,3654,8633,3923,1632,7123,3612,5811,5951,3641,3141,4961,6002,9484,3813,3953,5654,1213,3903,3246,1936,8907,9197,7056,7264,9342,8733,0174,1512,9882,8342,5572,1881,8611,2871,3191,25155581511421361371385618624
       Short-term Debt 
0
0
0
0
0
0
0
0
50
50
50
50
50
50
50
50
50
50
1,063
1,063
758
3,441
5
4,698
5,635
5,623
4,842
0
1,433
1,032
1,039
1,040
1,052
1,388
336
340
344
349
354
0
0
0
0
0
0
0
0
92
0
91
93
9391092000000003543493443403361,3881,0521,0401,0391,0321,43304,8425,6235,6354,69853,4417581,0631,0635050505050505050505000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,063
1,063
0
3,441
7,508
3,706
4,636
4,617
977
2,818
0
1,027
1,034
1,040
1,047
1,383
334
339
344
349
353
538
1,582
368
0
0
0
0
0
0
0
0
0
0000000003681,5825383533493443393341,3831,0471,0401,0341,02702,8189774,6174,6363,7067,5083,44101,0631,063000000000000000000
       Accounts payable 
4
6
17
24
33
42
46
47
98
0
5
70
144
182
371
522
393
455
326
338
401
275
329
1,984
2,047
2,296
1,978
298
1,868
2,358
1,072
892
775
940
320
293
1,073
921
853
872
849
820
860
1,050
1,316
1,179
1,240
1,422
2,781
1,625
1,674
1,6741,6252,7811,4221,2401,1791,3161,0508608208498728539211,0732933209407758921,0722,3581,8682981,9782,2962,0471,98432927540133832645539352237118214470509847464233241764
       Other Current Liabilities 
0
56
1
32
55
45
40
45
3
8
5
131
71
42
68
46
23
8
68
46
23
1,624
1,624
44
23
1,611
70
0
23
1,655
1,930
5
5
524
2,215
967
79
44
157
0
0
2,055
1,722
2,025
2,030
3,156
6,654
2,454
2,483
2,836
4,573
4,5732,8362,4832,4546,6543,1562,0302,0251,7222,0550015744799672,215524551,9301,655230701,61123441,6241,6242346688234668427113158345404555321560
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
8
0
0
0
0
400
400
400
400
310
317
804
848
2,909
1,448
772
733
764
0
4,847
4,914
4,922
4,989
5,057
6,896
7,125
8,242
8,252
8,326
7,951
8,005
5,081
5,127
5,543
5,696
5,645
5,341
5,631
5,721
5,800
6,580
6,690
6,6906,5805,8005,7215,6315,3415,6455,6965,5435,1275,0818,0057,9518,3268,2528,2427,1256,8965,0574,9894,9224,9144,84707647337721,4482,90984880431731040040040040000008000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
400
400
400
400
45
45
46
46
2,909
1,448
772
733
764
0
4,847
4,914
4,922
4,989
5,057
0
5,123
5,758
5,835
5,912
5,565
0
0
0
0
0
0
0
0
0
0
0
0
0000000000005,5655,9125,8355,7585,12305,0574,9894,9224,9144,84707647337721,4482,9094646454540040040040000000000000000
       Other Liabilities 
0
15
31
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,845
1,845
2,340
2,340
2,340
2,340
2,340
0
0
0
119
0
0
0
0
0
0
0
00000001190002,3402,3402,3402,3402,3401,8451,84500000000000000000000000000000031150
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,900
5,900
7,800
7,800
7,800
2,340
6,504
0
0
0
0
0
0
0
0
0
0
0
000000000006,5042,3407,8007,8007,8005,9005,900000000000000000000000008000000000
> Total Stockholder Equity
18
10
9
12
0
0
0
0
-94
-5
-50
-189
-581
-1,052
844
-763
-1,695
-2,579
-2,817
-3,238
-2,372
-2,896
-3,429
-4,889
-6,332
-7,817
-6,967
-6,203
-6,164
-5,384
-6,161
-6,178
-6,760
-362
999
4,440
1,162
1,022
768
4,648
-2,338
-3,424
-3,733
-4,380
-4,825
-6,161
-9,751
-5,955
-7,657
-7,429
-9,534
-9,534-7,429-7,657-5,955-9,751-6,161-4,825-4,380-3,733-3,424-2,3384,6487681,0221,1624,440999-362-6,760-6,178-6,161-5,384-6,164-6,203-6,967-7,817-6,332-4,889-3,429-2,896-2,372-3,238-2,817-2,579-1,695-763844-1,052-581-189-50-5-9400001291018
   Common Stock
3
3
3
3
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
5
5
5
5
5
5
6
6
6
6
6
6
6
6
12
11
13
13
13
13
14
14
15
16
19
19
0
0
24
0
28
29
292802400191916151414131313131112666666665555554444433333333333333
   Retained Earnings Total Equity000000000000-46,541-42,714-41,850-39,453-37,548-37,468-35,440-34,004-33,140-31,335-28,9920-26,680-25,001-22,238-20,800-19,159-18,594-18,070-16,886-13,627-11,739-10,785-4,463-2,760000-161-117-1090000000-6
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15
0
0150000000000000000000000000000000000000000000000000
   Capital Surplus 
12
0
0
0
0
0
0
0
12
108
0
108
108
144
3,599
3,619
9,033
9,088
10,632
10,747
15,673
15,693
15,724
15,924
15,924
17,160
19,544
0
22,864
25,994
26,966
27,812
28,623
37,094
38,401
41,593
43,201
44,027
47,763
0
0
0
0
0
0
0
0
0
0
0
0
00000000000047,76344,02743,20141,59338,40137,09428,62327,81226,96625,99422,864019,54417,16015,92415,92415,72415,69315,67310,74710,6329,0889,0333,6193,599144108108010812000000012
   Treasury Stock000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
9
0
0
0
0
0
0
0
0
0
0
96
54
14
0
77
53
67
174
2,896
20
0
0
-19
-24
19
162
159
-41
-49
8
8
50
0
135
2,287
-202
-304
-468
4,458
4,530
135
43
75
89
0
0
64,304
0
65,005
65,184
65,18465,005064,304008975431354,5304,458-468-304-2022,28713505088-49-4115916219-24-1900202,896174675377014549600000000009



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue40
Cost of Revenue-427
Gross Profit-388-388
 
Operating Income (+$)
Gross Profit-388
Operating Expense-2,363
Operating Income-2,751-2,751
 
Operating Expense (+$)
Research Development125
Selling General Administrative2,238
Selling And Marketing Expenses0
Operating Expense2,3632,363
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1,205
Other Finance Cost-0
Net Interest Income-1,205
 
Pretax Income (+$)
Operating Income-2,751
Net Interest Income-1,205
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,0602,558
EBIT - interestExpense = -3,956
-8,060
-6,855
Interest Expense1,205
Earnings Before Interest and Taxes (EBIT)-2,751-6,855
Earnings Before Interest and Taxes (EBITDA)-2,324
 
After tax Income (+$)
Income Before Tax-8,060
Tax Provision-0
Net Income From Continuing Ops-8,060-8,060
Net Income-8,060
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,790
Total Other Income/Expenses Net-5,3091,205
 

Technical Analysis of Axim Biotechnologies Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Axim Biotechnologies Inc. The general trend of Axim Biotechnologies Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Axim Biotechnologies Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Axim Biotechnologies Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.003 < 0.004 < 0.005.

The bearish price targets are: 0.002 > 0.002 > 0.002.

Tweet this
Axim Biotechnologies Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Axim Biotechnologies Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Axim Biotechnologies Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Axim Biotechnologies Inc. The current macd is -0.0005567.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Axim Biotechnologies Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Axim Biotechnologies Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Axim Biotechnologies Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Axim Biotechnologies Inc Daily Moving Average Convergence/Divergence (MACD) ChartAxim Biotechnologies Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Axim Biotechnologies Inc. The current adx is 20.29.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Axim Biotechnologies Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Axim Biotechnologies Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Axim Biotechnologies Inc. The current sar is 0.00529648.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Axim Biotechnologies Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Axim Biotechnologies Inc. The current rsi is 45.03. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Axim Biotechnologies Inc Daily Relative Strength Index (RSI) ChartAxim Biotechnologies Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Axim Biotechnologies Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Axim Biotechnologies Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Axim Biotechnologies Inc Daily Stochastic Oscillator ChartAxim Biotechnologies Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Axim Biotechnologies Inc. The current cci is -91.50326797.

Axim Biotechnologies Inc Daily Commodity Channel Index (CCI) ChartAxim Biotechnologies Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Axim Biotechnologies Inc. The current cmo is -4.99129354.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Axim Biotechnologies Inc Daily Chande Momentum Oscillator (CMO) ChartAxim Biotechnologies Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Axim Biotechnologies Inc. The current willr is -66.66666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Axim Biotechnologies Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Axim Biotechnologies Inc Daily Williams %R ChartAxim Biotechnologies Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Axim Biotechnologies Inc.

Axim Biotechnologies Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Axim Biotechnologies Inc. The current atr is 0.00084431.

Axim Biotechnologies Inc Daily Average True Range (ATR) ChartAxim Biotechnologies Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Axim Biotechnologies Inc. The current obv is -37,733,523.

Axim Biotechnologies Inc Daily On-Balance Volume (OBV) ChartAxim Biotechnologies Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Axim Biotechnologies Inc. The current mfi is 42.37.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Axim Biotechnologies Inc Daily Money Flow Index (MFI) ChartAxim Biotechnologies Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Axim Biotechnologies Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Axim Biotechnologies Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Axim Biotechnologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.030
Ma 20Greater thanMa 500.004
Ma 50Greater thanMa 1000.004
Ma 100Greater thanMa 2000.007
OpenGreater thanClose0.002
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Axim Biotechnologies Inc with someone you think should read this too:
  • Are you bullish or bearish on Axim Biotechnologies Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Axim Biotechnologies Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Axim Biotechnologies Inc

I send you an email if I find something interesting about Axim Biotechnologies Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Axim Biotechnologies Inc.

Receive notifications about Axim Biotechnologies Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.